Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Audited Financial Results For The Quarter And Year Ended 31St March 2020

 Pursuant to Regulations 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors in its meeting held on today i.e. 12th June 2020 has interalia considered and approved: 1. Audited Financial Results for the Quarter and Year ended 31st March 2020. Copy of the said financial results along with unmodified Auditors Report thereon is enclosed herewith. 2. Re-appointment of Mr Vikas Gupta as Executive Director of the Company for five years with effect from 29 May 2020 to 28 May 2025, subject to the approval of the members. We hereby confirm and declare that Auditors Report issued by the Statutory Auditors on the financial results of the Company for the financial year ended 31st March 2020 is an unmodified report. The meeting of Board of Directors commenced at 04:15 PM and concluded at 06:00 PM.
12-06-2020
Bigul

Annual report for IOL Chemicals and Pharmaceuticals Ltd. for FY-2020
12-06-2020
Bigul

IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Allotment

 This is to inform you that the Allotment Committee of the Board of Directors in its meeting held today i.e. 08 June 2020 at 10:30 AM has allotted 7,00,000 Equity Shares of Rs 10/- each at a premium of Rs 195/- per share to M/s NCVI Enterprises Limited (Promoter group company) upon exercise of the option attached with the Warrants, allotted on 30 March 2019. The said shares shall remain locked-in for a period of three year from the date of trading approval. Consequent upon the issue of the above 7,00,000 equity shares, the total paid-up capital of the Company stands increased to 5,75,87,502 fully paid equity shares of Rs 10/- each. The meeting concluded at 11:05 AM. This is for your information & record please.
08-06-2020
Bigul

IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 In accordance with Regulation 47 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith copy of the Notice published in "Economic Times" and "Punjabi Jagran" on 5th June 2020, regarding Board Meeting of the Company scheduled to be held on 12th June 2020.
05-06-2020
Bigul

IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Board Meeting Intimation for Audited Financial Results Of The Company For The Quarter And Year Ended 31St March 2020

 IOL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/06/2020 ,inter alia, to consider and approve In terms of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors is scheduled to be held on Friday, the 12th June 2020 inter-alia to consider and approve the audited financial results of the Company for the quarter and year ended 31st March 2020. Further, pursuant to the requirements of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's 'Code of Conduct to Regulate, Monitor and Reporting of Trading by Designated Persons', the Trading Window is closed with effect from 01st April 2020 till expiry of 48 hours from the date of financial results for quarter and year ended 31st March 2020 are made public. Accordingly, the trading window shall reopen from 15th June 2020.
04-06-2020
Bigul

IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vasudeva Commercial Ltd
28-05-2020
Bigul

IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Non-Applicability Of SEBI Circular Dated November 26, 2018 With Regard To Borrowings By Large Corporates (LC)

 Dear Sir, This is with reference to the SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018, in respect of raising of funds by issuance of debt securities by Large Corporates (LC) and disclosures and compliances thereof by such Large Corporates (LC). In this regard, we would like to inform you that our company is not falling under the category of 'Large Corporate (LC)" as per the framework provided in the aforesaid Circular. You are requested to kindly take the same on record.
05-05-2020
Bigul

IOL Chemicals & Pharmaceutical's stock more than doubles from March lows

 The stock surpassed its previous high of Rs 316.80, touched on February 27, 2020
29-04-2020
Bigul

IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Intimation For Recognition Of Company By Ministry Of Commerce & Industry As Three Star Export House

 With reference to the captioned subject, we would like to intimate that the Company has been recognized as a Three Star Export House by the Ministry of Commerce & Industry,Government of India and accordingly a Three Star Export House Recognition Certificate has been issued to the Company in accordance with the provisions of the Foreign Trade Policy 2015-2020 by upgrading its Two Star Export House Status. The certificate shall be valid for a period of five years. This will facilitate the company to expand its product portfolio in the Foreign Market.
28-04-2020
Bigul

IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Certificate Under Clause 40(9) Of SEBI (Listing Obligations And Disclosure Requirements)Regulations, 2015

 Pursuant to Clause 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations,2015, please find enclosed herewith a certificate received from Practicing Company Secretary for the half year ended 31 March 2020.
21-04-2020
Next Page
Close

Let's Open Free Demat Account